about
Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in ratsPerirenal Edema as a potential hint towards primary hypertension-Preliminary findings in MRI breast cancer stagingElevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus studyInhibition of the purinergic P2X7 receptor improves renal perfusion in angiotensin-II-infused rats.Association of GSTT1 and GSTM1 polymorphisms with blood pressure: A Bayesian modeling of continuous data.Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study.Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept.Hyperuricemia and incident heart failure.Genetics of salt-sensitive hypertension.Uric acid and dementia in community-dwelling older persons.Acute kidney injury: a springboard for progression in chronic kidney diseaseSerum uric acid levels are associated with polymorphism in the SAA1 gene in Chinese subjects.Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studiesSoluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.The pathophysiology of hypertension in patients with obesity.Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases.Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysisAngiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.From Brain to Behavior: Hypertension's Modulation of Cognition and AffectAssociation of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study).High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?Hypertension, kidney, and transgenics: a fresh perspective.Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertensionAssociation between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study.Salt, the kidneys, and arterial hypertension.Blood pressure follows the kidney: Perinatal influences on hereditary hypertensionPathogenesis of essential hypertension: historical paradigms and modern insights.Uric acid and inflammatory markersFemale spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males.Uric acid correlates to oxidation and inflammation in opposite directions in women.MicroRNA: a new frontier in kidney and blood pressure research.The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review.The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.Hypertension management: rationale for triple therapy based on mechanisms of action.Obesity-related cardiorenal disease: the benefits of bariatric surgery.Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies.The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study.Uric acid and fibrinogen: age-modulated relationships with blood pressure components.
P2860
Q24646456-0E44D47F-8468-4BA8-B3B1-0B738659C135Q26743419-05428F8D-088F-4322-A540-661123520726Q28744401-BB4C6AA5-2CB7-487E-B1D2-9E7595E8CC05Q30384751-0165093C-9B0B-4EB5-9088-259921D38ABCQ30832426-D7753CDA-DCCF-47A5-A5C0-3216250CE7A2Q30834519-3A5076CE-27A1-4EDF-AEF1-534119B46D6FQ31140484-A51412C3-5AB1-4463-82F7-F7288AD3BADDQ33572047-563FF834-C100-4C0B-9343-239CA283F561Q33603268-50551F20-EE34-49B0-94B5-3E4ED02FF90FQ33646553-8433FD51-CC08-4000-81C4-7A1B9C65E91EQ33840576-C22C1681-2537-4702-B0C5-BAE2A2727E2CQ34328823-2AC67961-C13F-4103-8F5C-083F0A0D2683Q34601785-69457EC7-51E2-4832-A967-801B444888D0Q34783515-D0E15020-10F7-47BE-81EF-3F87C33A1395Q35021492-DFB7A62F-06CD-4C4B-9B0F-D9888C83BEECQ35056901-B80A93F9-4B69-47BB-8D3D-1ED1935D45B2Q35572325-2982A998-F446-4899-82E1-0FF61AD25954Q35749652-EDA732B4-ADCC-4C59-A1EB-7350708515FBQ35810721-EBAF5B3A-3659-41C4-8E44-8FEEA77412D8Q36113099-6FC614F6-04EC-4079-A260-5D7F9D309F54Q36208883-13A7E644-397D-48A5-8718-AF270DD7F4DBQ36267702-0D6279E5-A527-477A-AB23-0EF99931536CQ36443015-07F3FF7E-E416-4622-883E-DB1D3E2394E0Q36936578-F71068D1-155D-4579-80B9-3566C4E7A0EEQ36941514-480CF031-3FFC-4560-8235-4E3AFB721216Q37070973-2801991C-46C4-4DEC-AEF1-2A472981C534Q37081774-0D793FC8-AD61-4320-A5CB-A8A4A40F618CQ37094953-C4131F77-667B-43C8-9CD1-E3DE55F480A3Q37156498-5E7EC560-6491-49BF-99AE-DD1155E1116DQ37174707-903B1200-BC54-4D27-A02D-2B5C21B754E2Q37185649-E6BB275C-C8A8-4E64-9F4C-54930C9ABD1EQ37337320-98F5D0B9-D53A-4F7F-BC5C-437AFF9AAD86Q37982966-87605386-7923-42F9-A584-B7CCC8F72171Q38047387-0AE80033-21CE-4E8B-B494-9816CAA56633Q38057421-68073F0D-DDB1-45B4-A1EE-EF0275B6B4C3Q38126800-8B612069-A0AD-4701-8A34-91E226BA0A23Q38208730-287EC110-DF4A-42BF-85CB-746A0ECCCDF4Q39449598-6BABF883-29C1-41AA-9859-12FCC44610BDQ39770827-36AC2239-CF76-4394-9BC8-088DD4D75C5FQ43608310-A4177FE9-069A-4106-A441-03104EE9E1CF
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A unifying pathway for essential hypertension.
@ast
A unifying pathway for essential hypertension.
@en
A unifying pathway for essential hypertension.
@nl
type
label
A unifying pathway for essential hypertension.
@ast
A unifying pathway for essential hypertension.
@en
A unifying pathway for essential hypertension.
@nl
prefLabel
A unifying pathway for essential hypertension.
@ast
A unifying pathway for essential hypertension.
@en
A unifying pathway for essential hypertension.
@nl
P2093
P1476
A unifying pathway for essential hypertension.
@en
P2093
Bernardo Rodriguez-Iturbe
Daniel I Feig
Duk-Hee Kang
Jaime Herrera-Acosta
Richard J Johnson
P304
P356
10.1016/J.AMJHYPER.2004.08.035
P577
2005-03-01T00:00:00Z